Why Are Blood Tests Important for Dogs with Liver Disease?

For instance, ALT is an enzyme that leaks into the bloodstream when liver cells are damaged. Elevated levels indicate hepatocellular injury or inflammation. ALP, on the other hand, is primarily produced by bile ducts and bone tissue but can also be elevated in cases of liver disease due to cholestasis or biliary obstruction. GGT is another marker for liver damage, particularly useful in distinguishing between hepatic and extrahepatic causes.
These markers are essential because they help differentiate between various types of liver disorders, such as hepatitis, cirrhosis, or bile duct obstruction. For example, high ALP with normal ALT often suggests biliary disease, while elevated GGT may indicate drug-induced hepatotoxicity or copper storage diseases like those seen in Bedlington Terriers and West Highland White Terriers.
- ALT: The reference range for ALT is 17-95 U/L. Elevated levels can be associated with liver inflammation, necrosis, or toxic injury.
- ALP: ALP has a reference range of 7-115 U/L, and its elevation may indicate biliary obstruction, bone disease, or hepatocellular damage.
- GGT: GGT typically falls within the range of 0-8 U/L. Increased levels often suggest cholestasis or drug-induced liver injury.
In addition to these markers, other tests such as total bilirubin and albumin provide further insights into liver function. Bilirubin measures the breakdown of red blood cells and liver excretion capacity, while low albumin can indicate protein synthesis impairment due to severe liver disease.
What Does a Complete Blood Count (CBC) Reveal About Liver Health?
The complete blood count (CBC) is a routine diagnostic test that provides information about various components of the blood, including red and white blood cells. While the CBC does not directly measure liver function or health, certain parameters within it can indirectly suggest issues related to the liver.
- Red Blood Cells (RBCs): Liver disease can lead to anemia due to decreased production of erythropoietin by the kidneys. Erythropoietin stimulates red blood cell production, and its deficiency can result in a decrease in RBC count.
- Hemoglobin: Hemoglobin levels may be low if there is liver dysfunction affecting erythropoiesis or due to bleeding disorders associated with liver disease.
- Hematocrit (Hct): The hematocrit, which measures the proportion of red blood cells in whole blood, can also indicate anemia related to liver issues. A low hematocrit suggests a decrease in RBC mass.
The CBC parameters mentioned above should be interpreted alongside other specific liver function tests such as alanine transaminase (ALT), alkaline phosphatase (ALP), and bilirubin levels. Elevated ALT, ALP, or bilirubin can indicate hepatocellular damage, cholestasis, or hemolysis associated with liver disease.
For example, in a dog showing signs of lethargy, poor appetite, and jaundice, an abnormal CBC might reveal low RBC count, hemoglobin, and hematocrit levels. These findings should prompt further investigation into liver function through additional tests like serum biochemistry panels to confirm the presence of liver disease.
It is important to note that while these parameters can suggest potential liver issues, they do not provide a definitive diagnosis on their own. A comprehensive evaluation by a veterinarian, including imaging studies and specific biochemical markers, is necessary for accurate diagnosis and treatment planning.
Understanding Elevated Liver Enzyme Levels in Blood Tests

Elevated liver enzyme levels, such as alanine aminotransferase (ALT), alkaline phosphatase (ALP), and gamma-glutamyl transferase (GGT), indicate potential damage or inflammation within the liver. These enzymes are normally present inside liver cells but spill into the bloodstream when cell walls are compromised due to injury, disease, or other factors.
For dogs, a value above the normal reference range for these markers warrants further investigation by a veterinarian. ALT (17-95 U/L) is particularly sensitive to hepatocellular injury and often rises in conditions like hepatitis or toxic damage. ALP (7-115 U/L), on the other hand, can be elevated due to biliary obstruction, bone disease, or certain drug effects. GGT (0-8 U/L) is more specific for bile duct issues but also increases with liver inflammation.
When interpreting these results, it’s crucial to consider them alongside other clinical signs and laboratory findings. For instance, bilirubin levels may be elevated in cases of hemolysis or hepatic dysfunction, while albumin (3.2-4.1 g/dL) might decrease if the liver is unable to produce sufficient proteins. Elevated ALT can also indicate acute hepatocellular damage from toxins such as certain medications, heavy metals, or plant ingestion. ALP elevation often suggests a problem with bile flow or bone metabolism, whereas GGT elevation points more specifically towards issues within the biliary system.
It is important to note that while elevated liver enzymes are indicative of potential liver disease, they do not provide specific information about the underlying cause. Therefore, further diagnostic tests such as imaging studies (ultrasound), bile acid testing, or a liver biopsy may be necessary to determine the exact nature and extent of liver damage.
| Marker | Normal Range | Possible Causes |
|---|---|---|
| ALT (Alanine Aminotransferase) | 17-95 U/L | Hepatitis, toxicosis, necrosis |
| ALP (Alkaline Phosphatase) | 7-115 U/L | Biliary obstruction, bone disease, drug effects |
| GGT (Gamma-Glutamyl Transferase) | 0-8 U/L | Bile duct issues, liver inflammation |
| Bilirubin | Laboratory-specific | Hemolysis, hepatic dysfunction |
| Albumin | 3.2-4.1 g/dL | Liver insufficiency, protein loss |
See the full reference intervals for the dog — every value cited to the laboratory document or paper it came from.
How Do Kidney Markers Relate to Liver Disease?
Kidney markers such as blood urea nitrogen (BUN) and creatinine are often evaluated alongside liver function tests like alanine aminotransferase (ALT), alkaline phosphatase (ALP), and bilirubin. These markers provide insight into the overall metabolic status of an animal, particularly in cases where both kidney and liver functions may be compromised.
BUN is primarily produced by the breakdown of proteins in the liver and excreted by the kidneys. Elevated BUN levels can indicate reduced renal function or dehydration, but they also suggest potential hepatic issues such as portosystemic shunts or severe hepatocellular damage. In cases where both BUN and ALT are elevated, it is crucial to investigate further for concurrent kidney and liver dysfunction.
Creatinine, another marker of kidney function, can be influenced by muscle mass but also reflects glomerular filtration rate (GFR). Elevated creatinine levels may indicate severe renal impairment or dehydration. When combined with high ALP levels, this pattern often suggests a more advanced stage of disease affecting both organs.
ALP is primarily associated with liver and bone metabolism but can be elevated in conditions that affect bile flow or obstruct the biliary system. In such cases, ALP elevation may also reflect underlying kidney issues due to metabolic disturbances caused by impaired hepatic function.
- BUN (9-26 mg/dL): Elevated BUN levels should prompt a thorough evaluation of both renal and liver functions, especially in the context of other markers like ALT and ALP.
- Creatinine (0.6-1.4 mg/dL): High creatinine levels indicate reduced kidney function but can also be influenced by hepatic conditions that affect protein metabolism.
- ALP (7-115 U/L): Elevated ALP may suggest biliary obstruction or liver disease, which in turn can impact renal function due to metabolic imbalances.
The veterinarian will consider these markers alongside clinical signs and additional diagnostic tests such as urinalysis, abdominal ultrasound, and blood biochemistry panels to determine the underlying cause of elevated levels. Treatment may involve addressing both kidney and liver issues simultaneously, depending on the specific diagnosis.
Electrolyte Imbalances and Glucose Levels in Liver Disease

In liver disease, electrolyte imbalances and abnormal glucose levels can provide important clues about the underlying condition. Electrolytes such as sodium (143-150 mEq/L), potassium (4.1-5.4 mEq/L), chloride (106-114 mEq/L), calcium (9.4-11.1 mg/dL), phosphorus (2.7-5.4 mg/dL), and magnesium (1.6-2.4 mg/dL) are crucial for maintaining cellular function, nerve conduction, muscle contraction, and acid-base balance. In liver disease, these electrolytes can become imbalanced due to impaired renal excretion or altered gastrointestinal absorption.
For example, hypokalemia (low potassium levels) may occur in dogs with severe vomiting or diarrhea, leading to dehydration and fluid loss. Conversely, hyperkalemia (high potassium levels) can be seen in cases of Addison’s disease, where aldosterone deficiency leads to reduced sodium reabsorption and potassium excretion by the kidneys. In liver disease, hypocalcemia may result from decreased vitamin D activation or impaired calcium absorption due to malnutrition.
Glucose metabolism is also affected in liver disease. Elevated blood glucose levels (hyperglycemia) can occur secondary to stress, infection, or other metabolic disturbances that impair insulin function. In contrast, hypoglycemia (low blood glucose) may be observed in dogs with severe hepatic dysfunction due to reduced gluconeogenesis and glycogenolysis.
Electrolyte imbalances and abnormal glucose levels should be interpreted alongside liver enzymes such as alanine aminotransferase (